Saturday 14 February 2026
Home      All news      Contact us      RSS     
zimbabweonlinenews - 15 days ago

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis

Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential. Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy directly targeting the OX40 receptor expressed on pathogenic T-cells shows potential to deliver long-term disease control in patients with moderate-to-severe atopic dermatitis (msAD). Regulatory submission is planned in the first […] The post Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis appeared first on Zimbabwe Online News.


Latest News
Hashtags:   

Kyowa

 | 

Kirin

 | 

Regain

 | 

Control

 | 

Rocatinlimab

 | 

Development

 | 

Commercialization

 | 

Program

 | 

Demonstrating

 | 

Strong

 | 

Commitment

 | 

Address

 | 

Unmet

 | 

Medical

 | 

Atopic

 | 

Dermatitis

 | 

Sources